1. Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. (10th August 2014) Authors: Zhang, X.; Brooks, B.; Molyneaux, L.; Landy, E.; Banatwalla, R.; Wu, T.; Wong, J.; Su, B.; Yue, D. K. Other Names: Kengne Andre P. Academic Editor. Journal: International journal of endocrinology Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Issue 3 (June 2015) Authors: Williams, K.H.; Viera de Ribeiro, A.J.; Prakoso, E.; Veillard, A.S.; Shackel, N.A.; Bu, Y.; Brooks, B.; Cavanagh, E.; Raleigh, J.; McLennan, S.V.; McCaughan, G.W.; Bachovchin, W.W.; Keane, F.M.; Zekry, A.; Twigg, S.M.; Gorrell, M.D. Journal: Diabetes research and clinical practice Issue: Volume 108:Issue 3(2015) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The evolution of an MCS over southern England. Part 1: Observations. (13th May 2013) Authors: Clark, P. A.; Browning, K. A.; Morcrette, C. J.; Blyth, A. M.; Forbes, R. M.; Brooks, B.; Perry, F. Journal: Quarterly journal of the Royal Meteorological Society Issue: Volume 140:Number 679(2014:Jan.) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗